Filed: 11/14/2025ACC: 0001104659-25-111932
📋 What this filing means
AVORO CAPITAL ADVISORS LLC filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $7.74B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$7.74B
Total AUM (reported)
164.34M
Total Shares
Allocation by class
COMMON$5.57B72.0%
SPONSORED ADR$2.01B26.0%
SPONSORED ADS$146.59M1.9%
CLASS A ORD$14.34M0.2%
Portfolio Concentration
Top 3$2.71B35.0%
4–10$2.90B37.5%
11–25$2.07B26.8%
Rest$57.82M0.7%
Top 3 weight
35.0%
Top 10 weight
72.5%
Voting Authority Distribution
Total shares with voting rights: 164.34M
Sole
Full voting authority
164.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
ASCENDIS PHARMA
SOLEShares5.11M
TypeSH
Market value$1.02B
13.13%
Sole
5.11M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares2.22M
TypeSH
Market value$852.18M
11.02%
Sole
2.22M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares1.83M
TypeSH
Market value$840.72M
10.87%
Sole
1.83M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares990K
TypeSH
Market value$730.18M
9.44%
Sole
990K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares2.78M
TypeSH
Market value$490.36M
6.34%
Sole
2.78M
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC.
SOLEShares10.90M
TypeSH
Market value$375.94M
4.86%
Sole
10.90M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares6.35M
TypeSH
Market value$359.41M
4.65%
Sole
6.35M
Shared
0.00
None
0.00
MERUS N V
SOLEShares3.54M
TypeSH
Market value$333.53M
4.31%
Sole
3.54M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares7.64M
TypeSH
Market value$333.09M
4.31%
Sole
7.64M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC.
SOLEShares12.22M
TypeSH
Market value$276.59M
3.58%
Sole
12.22M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares10.81M
TypeSH
Market value$262.10M
3.39%
Sole
10.81M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares4.44M
TypeSH
Market value$259.42M
3.35%
Sole
4.44M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares5.40M
TypeSH
Market value$216.81M
2.80%
Sole
5.40M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares3.96M
TypeSH
Market value$187.81M
2.43%
Sole
3.96M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares6.21M
TypeSH
Market value$180.46M
2.33%
Sole
6.21M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$174.26M
2.25%
Sole
2.58M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC.
SOLEShares5.41M
TypeSH
Market value$146.59M
1.89%
Sole
5.41M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares2.56M
TypeSH
Market value$122.23M
1.58%
Sole
2.56M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares10.25M
TypeSH
Market value$119.82M
1.55%
Sole
10.25M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC.
SOLEShares15.03M
TypeSH
Market value$118.40M
1.53%
Sole
15.03M
Shared
0.00
None
0.00
89BIO INC
SOLEShares6.39M
TypeSH
Market value$93.90M
1.21%
Sole
6.39M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares21.70M
TypeSH
Market value$70.96M
0.92%
Sole
21.70M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares2.24M
TypeSH
Market value$67.20M
0.87%
Sole
2.24M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares1.33M
TypeSH
Market value$25.64M
0.33%
Sole
1.33M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares1.34M
TypeSH
Market value$25.16M
0.33%
Sole
1.34M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASCENDIS PHARMASOLE | Sponsored ADR | 5.11M | SH | $1.02B 13.13% | 5.11M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | Common | 2.22M | SH | $852.18M 11.02% | 2.22M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | Common | 1.83M | SH | $840.72M 10.87% | 1.83M | 0.00 | 0.00 |
ARGENX SESOLE | Sponsored ADR | 990K | SH | $730.18M 9.44% | 990K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | Common | 2.78M | SH | $490.36M 6.34% | 2.78M | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INC.SOLE | Common | 10.90M | SH | $375.94M 4.86% | 10.90M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | Common | 6.35M | SH | $359.41M 4.65% | 6.35M | 0.00 | 0.00 |
MERUS N VSOLE | Common | 3.54M | SH | $333.53M 4.31% | 3.54M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | Common | 7.64M | SH | $333.09M 4.31% | 7.64M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INC.SOLE | Common | 12.22M | SH | $276.59M 3.58% | 12.22M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 10.81M | SH | $262.10M 3.39% | 10.81M | 0.00 | 0.00 |
UNIQURE NVSOLE | Common | 4.44M | SH | $259.42M 3.35% | 4.44M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | Common | 5.40M | SH | $216.81M 2.80% | 5.40M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | Common | 3.96M | SH | $187.81M 2.43% | 3.96M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | Common | 6.21M | SH | $180.46M 2.33% | 6.21M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | Common | 2.58M | SH | $174.26M 2.25% | 2.58M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INC.SOLE | SPONSORED ADS | 5.41M | SH | $146.59M 1.89% | 5.41M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | Common | 2.56M | SH | $122.23M 1.58% | 2.56M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | Common | 10.25M | SH | $119.82M 1.55% | 10.25M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INC.SOLE | Common | 15.03M | SH | $118.40M 1.53% | 15.03M | 0.00 | 0.00 |
89BIO INCSOLE | Common | 6.39M | SH | $93.90M 1.21% | 6.39M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | Common | 21.70M | SH | $70.96M 0.92% | 21.70M | 0.00 | 0.00 |
ALKERMES PLCSOLE | Common | 2.24M | SH | $67.20M 0.87% | 2.24M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | Common | 1.33M | SH | $25.64M 0.33% | 1.33M | 0.00 | 0.00 |
SEPTERNA INCSOLE | Common | 1.34M | SH | $25.16M 0.33% | 1.34M | 0.00 | 0.00 |
Page 1 of 2